Genkyotex announced the appointment of Dr. Daniel Elger as Chief Financial and Corporate Development Officer. He joins the company with more than 15 years biotech and pharmaceutical industry experience. Dr. Elger was most recently Chief Financial Officer and a Board Director of e-Therapeutics plc, where he played a central role in a substantial fundraising.

Prior to that role, he was Vice President, Marketing and Communications, at Antisoma plc, where he served on the Senior Management Team and had significant roles in corporate strategy, fundraisings and the acquisition of two US biotech companies, as well as directing the company's investor relations and communications programmes.